John Woodford

Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial

Aditya H. Gaur, James McCarthy, John C. Panetta et al. · The Lancet Infectious Diseases · 2020 · 74 citations

Antiparasitic Agent, Medicine, Malaria +5

The Dynamics of Liver Function Test Abnormalities after Malaria Infection: A Retrospective Observational Study

John Woodford, G. Dennis Shanks, Paul Griffin et al. · American Journal of Tropical Medicine and Hygiene · 2018 · 72 citations · Full text

A Phase 1, Placebo-controlled, Randomized, Single Ascending Dose Study and a Volunteer Infection Study to Characterize the Safety, Pharmacokinetics, and Antimalarial Activity of the <i>Plasmodium</i> Phosphatidylinositol 4-Kinase Inhibitor MMV390048

James McCarthy, Cristina Donini, Stephan Chalon et al. · Clinical Infectious Diseases · 2020 · 54 citations · Full text

Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Limited Clinical Disease in 3 Malian Communities: A Prospective Cohort Study

Issaka Sagara, John Woodford, Mamady Koné et al. · Clinical Infectious Diseases · 2021 · 39 citations · Full text

Early Endothelial Activation Precedes Glycocalyx Degradation and Microvascular Dysfunction in Experimentally Induced Plasmodium falciparum and Plasmodium vivax Infection

John Woodford, Tsin Wen Yeo, Kim A. Piera et al. · Infection and Immunity · 2020 · 38 citations · Full text